Isolated peptide or polypeptide of the extracellular portion of the human interferon receptor (IFN-R).
AssigneeMedisup International N.V.
InventorsPatrick Benoit, Francois Meyer, Debborah Maguire, Ivan Plavec, Michael G. Tovey
Life of this patent
Estimating the term…
Abstract
A monoclonal antibody is provided which is directed against the human interferon type I receptor (IFN-R), which recognizes the extracellular domain of the human IFN-R and which has neutralizing capacity against the biological properties of human type I-IFN. Diagnostic and therapeutic applications for the monoclonal antibody also are provided.
Claims5
An isolated peptide or polypeptide which is a fragment of the extracellular portion of the interferon receptor (IFN-R) of SEQ ID NO:
- 2, said peptide or polypeptide consisting of an amino acid sequence from position 27 to position 427 of SEQ ID NO:
- 2;
- wherein said peptide or polypeptide specifically binds to monoclonal antibody 64G12 deposited at the ECACC under No. 92022605.
An isolated peptide or polypeptide which is a fragment of the extracellular portion of the interferon receptor (IFN-R) of SEQ ID NO:
- 2, said peptide or polypeptide consisting of an amino acid sequence from position 1 to position 229 of SEQ ID NO:
- 2;
- wherein said peptide or polypeptide specifically binds to monoclonal antibody 64G12 deposited at the ECACC under No. 92022605.
An isolated peptide or polypeptide consisting of an amino acid sequence from position 1 to position 229 as set forth in SEQ ID NO:
- 2.
An isolated peptide or polypeptide consisting of an amino acid sequence from position 27 to position 427 as set forth in SEQ ID NO:
- 2.
Dependencies are inferred from the claim text.